SI-BONE, Inc. (SIBN)
USD 13.71
(-4.53%)
USD 13.71
(-4.53%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -46.93 Million USD | 21.27% |
| 2022 | -59.6 Million USD | -15.36% |
| 2021 | -51.67 Million USD | -33.97% |
| 2020 | -38.56 Million USD | -7.12% |
| 2019 | -36 Million USD | -200.9% |
| 2018 | -11.96 Million USD | 31.04% |
| 2017 | -17.35 Million USD | 1.22% |
| 2016 | -17.56 Million USD | 33.52% |
| 2015 | -26.42 Million USD | -0.46% |
| 2014 | -26.3 Million USD | -396.53% |
| 2013 | -5.29 Million USD | 50.58% |
| 2012 | -10.71 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -12.04 Million USD | 3.7% |
| 2024 Q2 | -10.07 Million USD | 16.32% |
| 2023 Q2 | -11.96 Million USD | -5.93% |
| 2023 Q1 | -11.29 Million USD | 0.01% |
| 2023 Q4 | -12.5 Million USD | -11.97% |
| 2023 FY | -46.93 Million USD | 21.27% |
| 2023 Q3 | -11.16 Million USD | 6.64% |
| 2022 Q2 | -17.88 Million USD | -6.01% |
| 2022 Q3 | -13.56 Million USD | 24.13% |
| 2022 Q4 | -11.29 Million USD | 16.75% |
| 2022 FY | -59.6 Million USD | -15.36% |
| 2022 Q1 | -16.86 Million USD | -21.09% |
| 2021 Q4 | -13.93 Million USD | -5.54% |
| 2021 Q3 | -13.19 Million USD | -1.8% |
| 2021 Q1 | -11.57 Million USD | -47.06% |
| 2021 FY | -51.67 Million USD | -33.97% |
| 2021 Q2 | -12.96 Million USD | -12.01% |
| 2020 Q4 | -7.87 Million USD | 9.27% |
| 2020 Q3 | -8.67 Million USD | 14.44% |
| 2020 FY | -38.56 Million USD | -7.12% |
| 2020 Q1 | -11.88 Million USD | -40.04% |
| 2020 Q2 | -10.13 Million USD | 14.67% |
| 2019 Q4 | -8.48 Million USD | 19.81% |
| 2019 Q3 | -10.58 Million USD | -30.02% |
| 2019 Q2 | -8.13 Million USD | 7.51% |
| 2019 FY | -36 Million USD | -200.9% |
| 2019 Q1 | -8.79 Million USD | -104.3% |
| 2018 Q2 | -1.69 Million USD | 41.82% |
| 2018 Q3 | -3.04 Million USD | -79.38% |
| 2018 Q4 | -4.3 Million USD | -41.49% |
| 2018 FY | -11.96 Million USD | 31.04% |
| 2018 Q1 | -2.91 Million USD | -77.76% |
| 2017 Q4 | -1.64 Million USD | 67.43% |
| 2017 Q1 | -5.55 Million USD | 0.0% |
| 2017 FY | -17.35 Million USD | 1.22% |
| 2017 Q2 | -4.67 Million USD | 15.79% |
| 2017 Q3 | -5.03 Million USD | -7.72% |
| 2016 Q1 | -6.48 Million USD | 0.0% |
| 2016 FY | -17.56 Million USD | 33.52% |
| 2015 Q1 | -6.85 Million USD | 12.82% |
| 2015 FY | -26.42 Million USD | -0.46% |
| 2014 Q1 | -3.48 Million USD | 0.0% |
| 2014 FY | -26.3 Million USD | -396.53% |
| 2014 Q4 | -7.86 Million USD | 0.0% |
| 2013 FY | -5.29 Million USD | 50.58% |
| 2012 FY | -10.71 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -226.795% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 13.136% |
| Bioventus Inc. | -81.72 Million USD | 42.574% |
| BrainsWay Ltd. | -4.92 Million USD | -852.527% |
| Cerus Corporation | -30.05 Million USD | -56.161% |
| Envoy Medical, Inc. | -18.37 Million USD | -155.462% |
| electroCore, Inc. | -18.8 Million USD | -149.567% |
| IceCure Medical Ltd | -15.57 Million USD | -201.303% |
| OrthoPediatrics Corp. | -25.76 Million USD | -82.143% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 3.199% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -171.78% |
| MaxCyte, Inc. | -48.29 Million USD | 2.832% |
| Nexalin Technology, Inc. | -5.69 Million USD | -723.886% |
| PAVmed Inc | -68.79 Million USD | 31.781% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -341.856% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 17.029% |
| RxSight, Inc. | -50.08 Million USD | 6.297% |
| Sight Sciences, Inc. | -57.27 Million USD | 18.059% |
| TELA Bio, Inc. | -44.07 Million USD | -6.48% |
| Talis Biomedical Corporation | -66.81 Million USD | 29.76% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 13.331% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 8.744% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -171.34% |
| Inogen, Inc. | -109.38 Million USD | 57.096% |
| Spectral AI, Inc. | -12.98 Million USD | -261.453% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 25.017% |
| CVRx, Inc. | -43.1 Million USD | -8.881% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1230.244% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -277.623% |
| Orthofix Medical Inc. | -139.11 Million USD | 66.263% |
| Venus Concept Inc. | -28.3 Million USD | -65.781% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -292.556% |
| LivaNova PLC | -68.49 Million USD | 31.486% |
| 908 Devices Inc. | -42.75 Million USD | -9.76% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 72.934% |
| Nemaura Medical Inc. | -9.59 Million USD | -389.107% |
| NeuroPace, Inc. | -27.17 Million USD | -72.706% |
| LENSAR, Inc. | -12.22 Million USD | -283.768% |
| Apyx Medical Corporation | -17.25 Million USD | -171.922% |
| Cutera, Inc. | -156.23 Million USD | 69.96% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -445.456% |
| BioSig Technologies, Inc. | -28.51 Million USD | -64.601% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 46.45% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -109.084% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 142.081% |
| Axonics, Inc. | -26.05 Million USD | -80.109% |
| Outset Medical, Inc. | -169.77 Million USD | 72.356% |
| IRIDEX Corporation | -10 Million USD | -368.982% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 57.011% |
| IRadimed Corporation | 20.03 Million USD | 334.24% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -469.206% |
| INVO Bioscience, Inc. | -6.76 Million USD | -593.512% |
| Telesis Bio, Inc. | -35.15 Million USD | -33.516% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 427.502% |
| Varex Imaging Corporation | 32.1 Million USD | 246.202% |
| Quipt Home Medical Corp. | 3.91 Million USD | 1297.525% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -286.805% |
| Pulmonx Corporation | -61.93 Million USD | 24.225% |
| Dynatronics Corporation | -2.27 Million USD | -1964.673% |
| Modular Medical, Inc. | -17.52 Million USD | -167.733% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -220.589% |
| Semler Scientific, Inc. | 22.25 Million USD | 310.869% |
| InMode Ltd. | 195.66 Million USD | 123.986% |
| Bruker Corporation | 436.9 Million USD | 110.742% |
| Cytosorbents Corporation | -31.2 Million USD | -50.375% |
| DexCom, Inc. | 597.7 Million USD | 107.852% |
| Align Technology, Inc. | 643.33 Million USD | 107.295% |
| Viveve Medical, Inc. | -21.55 Million USD | -117.747% |
| ZimVie Inc. | -30.93 Million USD | -51.689% |
| Movano Inc. | -29.69 Million USD | -58.07% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -68.544% |
| Nexalin Technology, Inc. | -5.69 Million USD | -723.886% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1230.244% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 79.878% |
| Profound Medical Corp. | -28.61 Million USD | -64.003% |
| Insulet Corporation | 220 Million USD | 121.332% |
| enVVeno Medical Corporation | -25.23 Million USD | -85.954% |
| Surmodics, Inc. | -5.64 Million USD | -731.373% |
| iCAD, Inc. | -7.68 Million USD | -510.365% |
| Nuwellis, Inc. | -17.63 Million USD | -166.2% |
| Biotricity, Inc. | -8.82 Million USD | -431.599% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 62.503% |
| Aethlon Medical, Inc. | -12.63 Million USD | -271.39% |
| InspireMD, Inc. | -21.14 Million USD | -121.969% |
| PAVmed Inc. | -68.79 Million USD | 31.781% |
| BIOLASE, Inc. | -17.93 Million USD | -161.644% |
| Beyond Air, Inc. | -63 Million USD | 25.513% |
| FONAR Corporation | 16.53 Million USD | 383.822% |
| AxoGen, Inc. | -21.46 Million USD | -118.67% |
| Vivani Medical, Inc. | -26.96 Million USD | -74.044% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 360.135% |
| Inari Medical, Inc. | -14.03 Million USD | -234.457% |
| UFP Technologies, Inc. | 57.66 Million USD | 181.387% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -852.411% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -644.255% |
| Tenon Medical, Inc. | -15.72 Million USD | -198.41% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -527.923% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -9.893% |
| AdaptHealth Corp. | -598.4 Million USD | 92.157% |
| Sintx Technologies, Inc. | -13.35 Million USD | -251.333% |
| NanoVibronix, Inc. | -3.43 Million USD | -1265.861% |
| Quanterix Corporation | -49.7 Million USD | 5.573% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -286.805% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -12185.602% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 85.968% |
| TransMedics Group, Inc. | -28.72 Million USD | -63.369% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -98.759% |
| NeuroMetrix, Inc. | -7.15 Million USD | -556.238% |
| Hyperfine, Inc. | -48.11 Million USD | 2.461% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 27.827% |
| Biomerica, Inc. | -6.36 Million USD | -637.098% |
| Bone Biologics Corporation | -9.42 Million USD | -397.767% |
| AVITA Medical, Inc. | -40.4 Million USD | -16.16% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -355.145% |
| Silk Road Medical, Inc | -59.27 Million USD | 20.82% |